LENZ Therapeutics, Inc. (LENZ) AI Dilution Summary

Estimated cash was $220,003,000 as of 2026-06-30, matching the cash reported at the 2026-06-30 balance-sheet date, against estimated monthly burn of $12,049,167. The company's operations are funded from that reported balance. Dilution here is driven mainly by the active S-3 shelf registration 333-286398.